Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma

Virchows Archiv

Volumn 427, Issue 4, 1995, Pages 431-436

  Segers, K ^a   Singh, S K ^a   Ramael, M ^a   Van Marck, E ^a   Backhovens, H ^b   De Voecht, J ^b   Van Broeckhoven, C ^b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Automated sequencing; Malignant mesothelioma; mdm2; p53

Indexed keywords

ANTIBODY; CELL PROTEIN; DNA; PROTEIN P53;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; STOP CODON; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; FEMALE; GENES, P53; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029563465     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/BF00199393     Document Type: Article

References (33)

1. Abnormal expression of wild type p53 protein in normal cells of a cancer family patient
2. p53 immunohistochemistry: a word of caution
3. A general method for the isolation of high molecular-weight DNA from eukaryotes
4. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens
5. Somatic mutations and human breast cancer. A status report
6. Tumorigenesis associated with the p53 tumour suppressor gene
7. Degradiation of nuclear oncoproteins by the ubiquitin system in vitro
8. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue carcinoma
9. Genetic alterations of the p53 gene are a feature of malignant mesotheliomas
10. Prognostic factors of malignant mesothelioma of the pleura
11. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas
12. p53 in tumour pathology: can we trust immunohistochemistry?-revisited!
13. The pathology of malignant mesothelioma, including immunohistology and ultrastructure
14. p53 expression is common in malignant mesothelioma
15. Characterization of the human p53 gene
16. p53 mutation and MDM2 amplification in human soft tissue sarcomas
17. The gene for human p53 cellular tumour antigen is located on chromosome 17 short arm (17p13)
18. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections
19. Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene
20. p53 and Kirsten- ras mutations in human mesothelioma cell lines
21. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features
22. p53 gene mutations in epithelial skin cancers
23. Asbestos: scientific developments and implications for public policy
24. Detection of aberrations of the p53 alleles and the gene transcript in human tumour cell lines by single-strand conformation polymorphism analysis
25. Aberrations of the tumour suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
26. Amplification of a gene encoding a p53-associated protein in human sarcomas
27. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
28. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium
29. Identification and characterization of a p53 mutation in a human osteosarcoma cell line
30. Expression from the murine p53 promoter is mediated by factor binding to a down-stream helix-loop-helix recognition motif
31. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumour-suppressor genes
32. Occurrence of Ki-ras and p53 mutations in primary colorectal tumours
33. p53 function and dysfunction